Expert Content | Pfizer CentreOne

Looking ahead: Today’s technical trends shaping 2021 priorities

A range of new treatment and administration routes are being introduced to pharma’s pipeline, bringing new complexities and prompting demand for experienced CDMOs.

Header image of scientist for 2021 CDMO trends blog

Webinar | An Overview of the Main Regulatory Issues Affecting the Pharmaceutical Industry

With the existence of a wide variety of regulatory approaches in the different knowledge areas, it becomes a priority to encourage regulatory harmonization.

A Beginner’s Guide to Technology Transfers

At the beginning of any commercial relationship with a CDMO, there is a technology transfer. Over the product lifecycle this may occur with other external partners and a product’s continued success can depend upon it.

The Importance of End-To-End Thinking During Drug Product Development - Outsourced Pharma

Throughout a drug product development program it is important to build robustness and flexibility into the manufacturing process. In this article, Dr.

Making the Medicine Go Down: Specialized Oral Solids Delivery Technologies

Most oral solids formulations are designed to release the drug immediately after swallowing for rapid absorption into the bloodstream.

Pfizer CentreOne's Partnership Promise

Strong commercial partnerships are based on trust and lasting relationships. For this reason, organizational changes can be unsettling. What will the new leader bring? What impact will the change have on my partnership? These are valid questions that should be addressed.

Oral Solid Dose Regulatory Hurdles and How to Approach Them

In your quest to meet the regulatory requirements for your oral solids project you may encounter significant hurdles. Anticipating these early on and thoroughly planning your approach can help.

Webinar | Key Trends in Contract Manufacturing

Growing demand for pharma and biotech outsourcing presents a tremendous opportunity for CDMOs, but the impact of COVID-19 adds to a growing list of considerations for finding the right commercial partners to deliver critical medicines. A recent CPhI webinar sponsored by Pfizer CentreOne she

Integrated CDMO Misconceptions

Access to the expert capabilities of embedded CDMOs is offering great economies and competitive experience. However, embedded CDMOs are still surrounded by misconceptions.

Webinar | Coating: Curing Your Complex Oral Solid Dose challenges

Coating technologies have been a mainstay in oral solid dose (OSD) drug development for many decades and deployed successfully in hundreds of drug products for multiple therapeutic areas.

The Three Key Ingredients to a Successful API Project

What’s the recipe for API project success?

Picking the Perfect API Partner

A 2018 report by analyst firm visiongain forecasts that the overallpharmaceutical contract manufacturing market is growing fast, achieving revenues of $84.0 billion by 2020 at a compound annual growth rate of 6.4% from 2015.

Insights & Resources